COMPARISON OF 3 DIFFERENT IMMUNOASSAYS FOR THE DETERMINATION OF CA 19-9 IN PANCREATIC CANCER PATIENTS - A NEW ASPECT OF POTENTIALLY CLINICAL RELEVANCE

被引：0
|
作者：
Klapdor, R. [1 ]
Bahlo, M. [1 ]
机构：
[1] ZeTDT GmbH, Internal Unit, Hamburg, Germany
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
328
引用
收藏
页码：5998 / 5999
页数：2
相关论文
共 50 条
  • [31] CLINICAL UTILITY OF TPS, TPA AND CA 19-9 MEASUREMENT IN PANCREATIC-CANCER
    PLEBANI, M
    BASSO, D
    DELFAVERO, G
    FERRARA, C
    MEGGIATO, T
    FOGAR, P
    MANGANO, F
    RICCIARDI, G
    BURLINA, A
    ONCOLOGY, 1993, 50 (06) : 436 - 440
  • [32] Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer
    Özkan, H
    Kaya, M
    Cengiz, A
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1669 - 1674
  • [33] Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
    Ballehaninna, Umashankar K.
    Chamberlain, Ronald S.
    TUMOR BIOLOGY, 2013, 34 (06) : 3279 - 3292
  • [34] EFFECT OF DIFFERENT TEST DESIGNS OF IMMUNOASSAYS ON HOOK EFFECT OF CA 19-9 MEASUREMENT
    WU, JT
    CHRISTENSEN, SE
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1991, 5 (03) : 228 - 232
  • [35] A CLINICAL-EVALUATION OF CARBOHYDRATE ANTIGEN 19-9 (CA 19-9) AND CARCINOEMBRYONIC ANTIGEN (GEA) IN PATIENTS WITH PANCREATIC-CARCINOMA
    SATAKE, K
    KANAZAWA, G
    KOH, I
    CHUNG, YS
    UMEYAMA, K
    DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (10) : 966 - 966
  • [36] CA 125 AND CA 19-9 AS TUMORAL MARKERS IN PANCREATIC-CANCER
    PASQUALI, C
    SPERTI, C
    DANDREA, AA
    PETRIN, P
    PEDRAZZOLI, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1986, 18 (04): : 235 - 235
  • [37] CA 19-9, miR-200 and GIP in patients with diabetes and pancreatic cancer
    Skrha, P.
    Horinek, A.
    Andel, M.
    Fric, P.
    Skrha, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S452 - S452
  • [38] Diagnostic Value of CA 19-9 in Patients with Pancreatic Cancer and Nonspecific Gastrointestinal Symptoms
    Safi F.
    Schlosser W.
    Kolb G.
    Beger H.G.
    Journal of Gastrointestinal Surgery, 1997, 1 (2) : 106 - 112
  • [39] Tumour associated antigen CA242 in pancreatic cancer: Comparison with established marker such as CA 19-9
    Cioffi, M
    Gazzerro, P
    Fratta, M
    DiFinizio, B
    Tucci, A
    Vietri, MT
    DeLucia, D
    Molinari, AM
    Puca, GA
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1997, 12 (01): : 39 - 44
  • [40] CA 19-9 IN PANCREATIC CANCER: RETROSPECTIVE EVALUATION OF 20 YEARS
    Molina, V.
    Visa, L.
    Conill, C.
    Navarro, S.
    Escudero, J. M.
    Auge, J. M.
    Filella, X.
    Fernandez Cruz, L.
    Ferrer, J.
    Molina, R.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1996 - 1996
12345